Clinical Trial Update: Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of fluvastatin, valsartan, and their combination in dyslipidemic patients with hypertension and endoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• Fluvastatin (fluvastatin)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Dyslipidemia | Phase 4 | Status: COMPLETED